Foundation Medical Partners
Description
Foundation Medical Partners (FMP) was a prominent US-based venture capital firm, established in 1999 in Norwalk, Connecticut. The firm specialized in early to growth-stage investments within the healthcare sector, focusing on healthcare information technology, services, and medical devices. FMP was known for its deep industry expertise and a hands-on approach, partnering with entrepreneurs to scale innovative healthcare solutions.
Over its active investment period, Foundation Medical Partners successfully raised multiple funds. Its last known fund, Foundation Medical Partners IV, closed in 2007 with $200 million in committed capital. This substantial fund size allowed FMP to make significant initial investments and provide follow-on funding to its portfolio companies. Notable investments included athenahealth, which went on to achieve a successful IPO, and Health Dialog, later acquired by Bupa. The firm's investment strategy aimed to identify companies poised to transform healthcare delivery and efficiency.
While Foundation Medical Partners is no longer actively making new investments under that specific name, its legacy continues through the subsequent ventures of its founding partners. For instance, Robert W. Faulkner, a key partner at FMP, later co-founded Flare Capital Partners, another highly respected healthcare-focused venture capital firm. This transition highlights the enduring impact and expertise of the team originally assembled at Foundation Medical Partners, contributing to the evolution of healthcare innovation.
Investor Profile
Foundation Medical Partners has backed more than 41 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 7% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Typical check size: $3M – $15M.
Stage Focus
- Series Unknown (24%)
- Series C (22%)
- Series B (15%)
- Series D (12%)
- Series E (10%)
- Series F (5%)
- Series A (5%)
- Series G (5%)
- Debt Financing (2%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Health Diagnostics
- Biotechnology
- Manufacturing
- Pharmaceutical
- Cosmetic Surgery
- Marketing
- Hospital
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
